Glucosio E Sodio Cloruro Iii Industria Farmaceutica Galenica Senese

Glucosio E Sodio Cloruro Iii Industria Farmaceutica Galenica Senese is an injectable solution that combines sodium chloride and glucose monohydrate. The product is supplied as a sterile intravenous fluid without a specified strength, intended for use in clinical settings. It is manufactured in the European Union and classified as a prescription‑only electrolyte and carbohydrate solution for fluid and energy replacement, and is commonly used under medical supervision.

Glucosio E Sodio Cloruro Iii is indicated for several clinical situations that require intravenous fluid and electrolyte management.

- Replacement of extracellular fluid volume in patients with dehydration or blood loss. - Correction of hyponatremia or other sodium deficits. - Provision of an immediate source of glucose for treatment of hypoglycemia. - Peri‑operative fluid management to maintain hemodynamic stability. - Support of parenteral nutrition regimens when combined with other nutrients.

Adverse reactions to the intravenous solution are generally infrequent, but they may vary in severity.

Common: - Mild local irritation at the infusion site. - Transient hyperglycemia. - Slight increase in serum sodium levels. - Nausea or mild vomiting. - Headache.

Serious: - Severe hypernatremia leading to neurologic symptoms. - Allergic or anaphylactic reaction. - Fluid overload with pulmonary edema. - Significant electrolyte imbalance causing cardiac arrhythmia.

Before administering Glucosio E Sodio Cloruro Iii, clinicians should evaluate patient-specific factors and monitor relevant parameters.

- Assess baseline serum electrolytes and glucose to avoid overcorrection. - Use caution in patients with renal impairment or congestive heart failure. - Adjust infusion rate in neonates, infants, and the elderly. - Avoid rapid administration in patients at risk for cerebral edema. - Monitor fluid balance and weight during therapy. - Discontinue if signs of allergic reaction appear.

The solution may interact with other intravenous agents or medications that affect fluid and electrolyte status.

Avoid: - Co‑administration with hypertonic saline solutions, which can cause excessive sodium load. - Simultaneous infusion of potassium‑containing fluids without appropriate monitoring.

Use with caution: - Concurrent use of insulin or oral hypoglycemic agents, which may amplify glucose effects. - Diuretics that alter sodium balance. - Corticosteroids that promote sodium retention.